Nov 4, 2022 This Week in Cardiology Podcast

Time to quadruple therapy, the disappointing AVANT GUARD trial, PFA risks, the TREAT-PVC trial, and NSTEMI care in the frail elderly are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial t ...  Show more

PCSK9 inhibitors in high-risk diabetes without ASCVD, the CAAN-AF trial, conduction system pacing vs biventricular pacing, PFA and stroke, and therapeutic fashion infects expert consensus are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended ...  Show more

For years, hot flashes and night sweats (aka vasomotor symptoms) were considered just a “bothersome” part of being a menopausal woman: we were to wear layers, buy a fan, and soldier on. Then researchers started making some troubling connections between vasomotor symptoms and chro ...  Show more

Menopause and age raise our cardiovascular disease risk. Athletes and highly active people also tend to have a higher prevalence of coronary artery calcium and atherosclerotic plaque (though it tends to be the benign kind). But what does that all mean? How can we know what’s real ...  Show more

Herausforderung Hormontherapie: Zwischen ernsten Risiken und hartnäckigen Missverständnissen 

Dr Eric Topol sits down with Mark Zuckerberg and Priscilla Chan to talk about the next phase of their ambitious Chan Zuckerberg Initiative. This podcast is intended for US healthcare professionals only. To read a full transcript of this episode or to comment please visit: https:/ ...  Show more